Effects of luteinizing hormone-releasing hormone analogue on DNA synthesis in rat prostate and uterus

S. Sakamoto, M. Tajima, K. Sawaki, S. Suzuki, H. Kudo, S. Sassa, K. Kuwa, Y. Sugiura, N. Kasahara, H. Nagasawa

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Buserelin, a potent LH-RH agonist, has been used for the treatment of hormonal disorders such as precocious puberty, endometriosis, cystic mastitis and prostatic carcinoma. Prolonged treatment with buserelin has been known to induce a refractory phase of pituitary desensitization. In the present study, we found that two-week treatment with buserelin strongly suppressed the activities of thymidylate synthetase and thymidine kinase, and markedly reduced the appearance of BrdU-immunoreactive (S-phase) cells in both prostate glands and uteri in male and female adult rats, respectively.

Original languageEnglish (US)
Pages (from-to)13-16
Number of pages4
JournalIn Vivo
Volume7
Issue number1
StatePublished - 1993

Fingerprint

Buserelin
Gonadotropin-Releasing Hormone
Uterus
Rats
Prostate
dTMP kinase
DNA
Precocious Puberty
Thymidylate Synthase
Thymidine Kinase
Mastitis
Bromodeoxyuridine
Endometriosis
S Phase
Refractory materials
Carcinoma

Keywords

  • BrdU
  • endometrium
  • LH-RH
  • prostate gland
  • thymidine kinase
  • thymidylate synthetase

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Sakamoto, S., Tajima, M., Sawaki, K., Suzuki, S., Kudo, H., Sassa, S., ... Nagasawa, H. (1993). Effects of luteinizing hormone-releasing hormone analogue on DNA synthesis in rat prostate and uterus. In Vivo, 7(1), 13-16.

Effects of luteinizing hormone-releasing hormone analogue on DNA synthesis in rat prostate and uterus. / Sakamoto, S.; Tajima, M.; Sawaki, K.; Suzuki, S.; Kudo, H.; Sassa, S.; Kuwa, K.; Sugiura, Y.; Kasahara, N.; Nagasawa, H.

In: In Vivo, Vol. 7, No. 1, 1993, p. 13-16.

Research output: Contribution to journalArticle

Sakamoto, S, Tajima, M, Sawaki, K, Suzuki, S, Kudo, H, Sassa, S, Kuwa, K, Sugiura, Y, Kasahara, N & Nagasawa, H 1993, 'Effects of luteinizing hormone-releasing hormone analogue on DNA synthesis in rat prostate and uterus', In Vivo, vol. 7, no. 1, pp. 13-16.
Sakamoto S, Tajima M, Sawaki K, Suzuki S, Kudo H, Sassa S et al. Effects of luteinizing hormone-releasing hormone analogue on DNA synthesis in rat prostate and uterus. In Vivo. 1993;7(1):13-16.
Sakamoto, S. ; Tajima, M. ; Sawaki, K. ; Suzuki, S. ; Kudo, H. ; Sassa, S. ; Kuwa, K. ; Sugiura, Y. ; Kasahara, N. ; Nagasawa, H. / Effects of luteinizing hormone-releasing hormone analogue on DNA synthesis in rat prostate and uterus. In: In Vivo. 1993 ; Vol. 7, No. 1. pp. 13-16.
@article{0285df0cfb414a929199d36dd799157f,
title = "Effects of luteinizing hormone-releasing hormone analogue on DNA synthesis in rat prostate and uterus",
abstract = "Buserelin, a potent LH-RH agonist, has been used for the treatment of hormonal disorders such as precocious puberty, endometriosis, cystic mastitis and prostatic carcinoma. Prolonged treatment with buserelin has been known to induce a refractory phase of pituitary desensitization. In the present study, we found that two-week treatment with buserelin strongly suppressed the activities of thymidylate synthetase and thymidine kinase, and markedly reduced the appearance of BrdU-immunoreactive (S-phase) cells in both prostate glands and uteri in male and female adult rats, respectively.",
keywords = "BrdU, endometrium, LH-RH, prostate gland, thymidine kinase, thymidylate synthetase",
author = "S. Sakamoto and M. Tajima and K. Sawaki and S. Suzuki and H. Kudo and S. Sassa and K. Kuwa and Y. Sugiura and N. Kasahara and H. Nagasawa",
year = "1993",
language = "English (US)",
volume = "7",
pages = "13--16",
journal = "In Vivo",
issn = "0258-851X",
publisher = "International Institute of Anticancer Research",
number = "1",

}

TY - JOUR

T1 - Effects of luteinizing hormone-releasing hormone analogue on DNA synthesis in rat prostate and uterus

AU - Sakamoto, S.

AU - Tajima, M.

AU - Sawaki, K.

AU - Suzuki, S.

AU - Kudo, H.

AU - Sassa, S.

AU - Kuwa, K.

AU - Sugiura, Y.

AU - Kasahara, N.

AU - Nagasawa, H.

PY - 1993

Y1 - 1993

N2 - Buserelin, a potent LH-RH agonist, has been used for the treatment of hormonal disorders such as precocious puberty, endometriosis, cystic mastitis and prostatic carcinoma. Prolonged treatment with buserelin has been known to induce a refractory phase of pituitary desensitization. In the present study, we found that two-week treatment with buserelin strongly suppressed the activities of thymidylate synthetase and thymidine kinase, and markedly reduced the appearance of BrdU-immunoreactive (S-phase) cells in both prostate glands and uteri in male and female adult rats, respectively.

AB - Buserelin, a potent LH-RH agonist, has been used for the treatment of hormonal disorders such as precocious puberty, endometriosis, cystic mastitis and prostatic carcinoma. Prolonged treatment with buserelin has been known to induce a refractory phase of pituitary desensitization. In the present study, we found that two-week treatment with buserelin strongly suppressed the activities of thymidylate synthetase and thymidine kinase, and markedly reduced the appearance of BrdU-immunoreactive (S-phase) cells in both prostate glands and uteri in male and female adult rats, respectively.

KW - BrdU

KW - endometrium

KW - LH-RH

KW - prostate gland

KW - thymidine kinase

KW - thymidylate synthetase

UR - http://www.scopus.com/inward/record.url?scp=0027315930&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027315930&partnerID=8YFLogxK

M3 - Article

C2 - 8504203

AN - SCOPUS:0027315930

VL - 7

SP - 13

EP - 16

JO - In Vivo

JF - In Vivo

SN - 0258-851X

IS - 1

ER -